CGEM
Price
$8.74
Change
-$0.33 (-3.64%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
515.79M
63 days until earnings call
EYPT
Price
$8.26
Change
+$0.06 (+0.73%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
567.7M
54 days until earnings call
Interact to see
Advertisement

CGEM vs EYPT

Header iconCGEM vs EYPT Comparison
Open Charts CGEM vs EYPTBanner chart's image
Cullinan Therapeutics
Price$8.74
Change-$0.33 (-3.64%)
Volume$6.83K
Capitalization515.79M
EyePoint Pharmaceuticals
Price$8.26
Change+$0.06 (+0.73%)
Volume$7.04K
Capitalization567.7M
CGEM vs EYPT Comparison Chart
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. EYPT commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Buy and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CGEM: $8.74 vs. EYPT: $8.25)
Brand notoriety: CGEM and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 71% vs. EYPT: 59%
Market capitalization -- CGEM: $515.79M vs. EYPT: $567.7M
CGEM [@Biotechnology] is valued at $515.79M. EYPT’s [@Biotechnology] market capitalization is $567.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CGEM and EYPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 6 TA indicator(s) are bullish while EYPT’s TA Score has 6 bullish TA indicator(s).

  • CGEM’s TA Score: 6 bullish, 4 bearish.
  • EYPT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CGEM and EYPT are a good buy in the short-term.

Price Growth

CGEM (@Biotechnology) experienced а +0.69% price change this week, while EYPT (@Biotechnology) price change was +14.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 07, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($568M) has a higher market cap than CGEM($516M). EYPT YTD gains are higher at: 10.738 vs. CGEM (-25.534). EYPT has higher annual earnings (EBITDA): -144.55M vs. CGEM (-208.62M). EYPT (318M) and CGEM (304M) have equal amount of cash in the bank . CGEM has less debt than EYPT: CGEM (1.84M) vs EYPT (24.1M). EYPT has higher revenues than CGEM: EYPT (56M) vs CGEM (0).
CGEMEYPTCGEM / EYPT
Capitalization516M568M91%
EBITDA-208.62M-144.55M144%
Gain YTD-25.53410.738-238%
P/E RatioN/AN/A-
Revenue056M-
Total Cash304M318M96%
Total Debt1.84M24.1M8%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMEYPT
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEMSX9.990.09
+0.91%
Janus Henderson Emerging Markets S
HDQVX17.770.13
+0.74%
Janus Henderson Responsible Intl DivS
CAPCX8.71N/A
N/A
Federated Hermes Capital Income C
BIGRX36.49N/A
N/A
American Century Discplnd Cor Val Inv
JNBSX9.96N/A
N/A
JPMorgan Income Builder I

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+1.23%
MDGL - CGEM
50%
Loosely correlated
-1.79%
FATE - CGEM
45%
Loosely correlated
+4.41%
EYPT - CGEM
45%
Loosely correlated
+0.99%
GOSS - CGEM
45%
Loosely correlated
+3.28%
DNLI - CGEM
45%
Loosely correlated
+3.52%
More